# Fate Therapeutics Inc: Form SC 13D/A, filed Dec 28, 2023

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: SC 13D/A
- Filed: 2023-12-28
- Accepted by EDGAR: Dec 28, 2023, 16:53 ET
- Period: not reported
- Accession: 0001104659-23-130098
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000110465923130098/tm2333829d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000110465923130098/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000110465923130098/tm2333829d1_sc13da.htm

Filed Dec 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-130098. Last ingested by Listed: Nov 5, 2026, 19:31 ET. No prices; not investment advice.